Search research articles
Contact Us
Filters
Showing results (1-10 of 56) with videos related to
Page
of 6
Sort By:
Circulation Research
|
April 11, 2015
Highlight on mouse endocan
Nathalie De Freitas Caires, Philippe Lassalle
Sleep & Breathing = Schlaf & Atmung
|
September 6, 2024
The effect of supplemental oxygen and continuous positive airway pressure withdrawal on endocan levels
Chris D Turnbull, John R Stradling, Nayia Petousi, et al.
Critical Care (London, England)
|
May 7, 2021
A high blood endocan profile during COVID-19 distinguishes moderate from severe acute respiratory distress syndrome
Tiffany Pascreau, Colas Tcherakian, Benjamin Zuber, et al.
Biomolecules
|
April 23, 2022
Endocan in Acute Leukemia: Current Knowledge and Future Perspectives
Håkon Reikvam, Kimberley Joanne Hatfield, Øystein Wendelbo, et al.
Expert Opinion on Investigational Drugs
|
October 17, 2008
In vivo biological effects of ATRA in the treatment of AML
Anita Ryningen, Camilla Stapnes, Kristin Paulsen, et al.
Leukemia Research
|
November 15, 2008
A subset of patients with high-risk acute myelogenous leukemia shows improved peripheral blood cell counts when treated with the combination of valproic acid, theophylline and all-trans retinoic acid
Anita Ryningen, Camilla Stapnes, Philippe Lassalle, et al.
In Vivo (Athens, Greece)
|
February 21, 2013
M14K and M38K malignant pleural mesothelioma cell lines preserve the same claudin-based phenotype in vivo
Siham Chaouche-Mazouni, Marie-Christine Copin, Philippe Lassalle, et al.
Critical Care (London, England)
|
October 28, 2018
Endocan, sepsis, pneumonia, and acute respiratory distress syndrome
Nathalie De Freitas Caires, Alexandre Gaudet, Lucie Portier, et al.
Expert Opinion on Investigational Drugs
|
January 7, 2010
Targeting the angiopoietin (Ang)/Tie-2 pathway in the crosstalk between acute myeloid leukaemia and endothelial cells: studies of Tie-2 blocking antibodies, exogenous Ang-2 and inhibition of constitutive agonistic Ang-1 release
Håkon Reikvam, Kimberley Joanne Hatfield, Philippe Lassalle, et al.
Hematology (Amsterdam, Netherlands)
|
December 21, 2011
Serum levels of endothelium-derived endocan are increased in patients with untreated acute myeloid leukemia
Kimberley Joanne Hatfield, Philippe Lassalle, Rafael Alexander Leiva, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 56) with videos related to
Sort By:
Page
of 6
Circulation Research
|
April 11, 2015
Highlight on mouse endocan
Nathalie De Freitas Caires, Philippe Lassalle
Sleep & Breathing = Schlaf & Atmung
|
September 6, 2024
The effect of supplemental oxygen and continuous positive airway pressure withdrawal on endocan levels
Chris D Turnbull, John R Stradling, Nayia Petousi, et al.
Critical Care (London, England)
|
May 7, 2021
A high blood endocan profile during COVID-19 distinguishes moderate from severe acute respiratory distress syndrome
Tiffany Pascreau, Colas Tcherakian, Benjamin Zuber, et al.
Biomolecules
|
April 23, 2022
Endocan in Acute Leukemia: Current Knowledge and Future Perspectives
Håkon Reikvam, Kimberley Joanne Hatfield, Øystein Wendelbo, et al.
Expert Opinion on Investigational Drugs
|
October 17, 2008
In vivo biological effects of ATRA in the treatment of AML
Anita Ryningen, Camilla Stapnes, Kristin Paulsen, et al.
Leukemia Research
|
November 15, 2008
A subset of patients with high-risk acute myelogenous leukemia shows improved peripheral blood cell counts when treated with the combination of valproic acid, theophylline and all-trans retinoic acid
Anita Ryningen, Camilla Stapnes, Philippe Lassalle, et al.
In Vivo (Athens, Greece)
|
February 21, 2013
M14K and M38K malignant pleural mesothelioma cell lines preserve the same claudin-based phenotype in vivo
Siham Chaouche-Mazouni, Marie-Christine Copin, Philippe Lassalle, et al.
Critical Care (London, England)
|
October 28, 2018
Endocan, sepsis, pneumonia, and acute respiratory distress syndrome
Nathalie De Freitas Caires, Alexandre Gaudet, Lucie Portier, et al.
Expert Opinion on Investigational Drugs
|
January 7, 2010
Targeting the angiopoietin (Ang)/Tie-2 pathway in the crosstalk between acute myeloid leukaemia and endothelial cells: studies of Tie-2 blocking antibodies, exogenous Ang-2 and inhibition of constitutive agonistic Ang-1 release
Håkon Reikvam, Kimberley Joanne Hatfield, Philippe Lassalle, et al.
Hematology (Amsterdam, Netherlands)
|
December 21, 2011
Serum levels of endothelium-derived endocan are increased in patients with untreated acute myeloid leukemia
Kimberley Joanne Hatfield, Philippe Lassalle, Rafael Alexander Leiva, et al.
Page
of 6